CASEBIA THERAPEUTICS

Welcome to the Brand page for “CASEBIA THERAPEUTICS”, which is offered here for Gene therapy products, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; gene therapy products, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders;therapeutics;research and development of human therapeutics using gene editing; pharmaceutical research and development services;.

Its status is currently believed to be active. Its class is unavailable. “CASEBIA THERAPEUTICS” is believed to be currently owned by “Casebia Therapeutics Limited Liability Partnership”.